NCT07136467Recruiting🇫🇷 With a site in France
A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa
Multi-Country, Cross-sectional Study to Characterize Real World Burden of Disease in Adolescent and Adult Patients With Alopecia Areata, Vitiligo or Hidradenitis Suppurativa (MEASURE AAVitHS)
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Recruiting
- Declared phase
- No phase declared
- Sponsor
- AbbVie
- Participants (registry)
- 2795
- Start
- September 2025
- Primary completion
- August 2027 (planned)
- Study completion
- August 2027 (planned)
- Last registry update
- February 2026
- Countries
- Argentina, Canada, Colombia, Czechia, Estonia, France, Germany, Greece, Italy, Japan, Latvia, Puerto Rico, Romania, South Korea, Spain, Switzerland, Taiwan, United Kingdom
Conditions studied: Non-Segmental Vitiligo (NSV), Alopecia Areata, Hidradenitis Suppurativa
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.